TELA Bio (TELA) Shareholder's Equity (2018 - 2026)

TELA Bio (TELA) Shareholder's Equity (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 52.06 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 22.98 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 10.33 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 10.67 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 13.34 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 2.96 Bn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 7.20 Bn
10 TELA Bio 49.36 Mn 9.81 Mn 12.52 Mn -5.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.20 Mn
Dec 31, 2025 6.31 Mn
Sep 30, 2025 1.56 Mn
Jun 30, 2025 9.18 Mn
Mar 31, 2025 18.12 Mn
Dec 31, 2024 28.46 Mn
Sep 30, 2024 -6.27 Mn
Jun 30, 2024 2.87 Mn
Mar 31, 2024 14.38 Mn
Dec 31, 2023 18.88 Mn
Sep 30, 2023 30.55 Mn
Jun 30, 2023 40.01 Mn
Mar 31, 2023 3.14 Mn
Dec 31, 2022 14.31 Mn
Sep 30, 2022 23.30 Mn
Jun 30, 2022 -1.54 Mn
Mar 31, 2022 10.04 Mn
Dec 31, 2021 20.10 Mn
Sep 30, 2021 27.73 Mn
Jun 30, 2021 34.97 Mn